Ajanta Pharma (AJANTPHARM) — Announcement

📢 Key Event
Nomination and Remuneration Committee allotted 23,400 equity shares upon option exercise.

🔄 What Changed
Paid-up capital increased to Rs 24,99,18,048

🔮 What's Next
Company will be making application for listing of these shares in due course

Ajanta Pharma announced that its Nomination and Remuneration Committee allotted 23,400 equity shares of Rs 2 each upon option exercise, increasing paid-up capital to Rs 24,99,18,048. The company will seek listing of the newly issued shares in due course.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AJANTPHARM ✨ Ask AI About This

About Ajanta Pharma Limited (AJANTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹39,694.55 Cr P/E: 37.6 ROE: 23.3% ROCE: 29.4%

View full AJANTPHARM stock details →

📡 Get AI alerts when AJANTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AJANTPHARM — Free

💡 Ask AI about this filing

"How will the new shares affect Ajanta Pharma's EPS?" "What is the expected timeline for listing the allotted shares?" "How does this issuance compare to recent capital raises by peers?"

Ask AI Free →

📊 More AJANTPHARM filings

See all AJANTPHARM filings →

🔥 Also filed on 30 July 2026

AYMSYNTEX AYM Syntex Limited Announcement GILLETTE Gillette India Limited Corporate Action GATEWAY Gateway Distriparks Limited Corporate Action PARADEEP Paradeep Phosphates Limited Financial Results SYRMA Syrma SGS Technology Limited Offer Document MAXESTATES Max Estates Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AJANTPHARM files new disclosures

Track AJANTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.